Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026
Vanda Pharmaceuticals (Nasdaq: VNDA) will announce fourth quarter and full year 2025 financial results on Wednesday, February 11, 2026 after market close.
Rhea-AI Summary
Vanda Pharmaceuticals (Nasdaq: VNDA) will announce fourth quarter and full year 2025 financial results on Wednesday, February 11, 2026 after market close. Management will host a conference call at 4:30 PM ET the same day and a simultaneous webcast will be available and archived on the company website.
Investors should register on the website at least 15 minutes early. Call-in numbers use passcode 8728050. A replay will be available beginning Feb 11, 2026 at 8:30 PM ET through Feb 18, 2026 at 11:59 PM ET with listed replay numbers.
Positive
- None.
Negative
- None.
Details
News Market Reaction – VNDA
On Feb 5, the first trading day after this news, VNDA closed 4.87% below the previous close.
Data tracked by StockTitan Argus for the Feb 5 session.
Key Figures
- Earnings release date
- February 11, 2026
- Q4 and full-year 2025 results release after market close
- Conference call time
- 4:30 PM ET
- Management call on February 11, 2026
- Conference call passcode
- 8728050
- Access code for live earnings conference call
- Replay availability window
- Feb 11–Feb 18, 2026
- Replay from 8:30 PM ET Feb 11 to 11:59 PM ET Feb 18
- Domestic dial-in
- 1-888-596-4144
- US access number for live conference call
Historical Context
-
FDA said HETLIOZ jet lag sNDA cannot be approved in current form.
-
FDA approved NEREUS to prevent motion-induced vomiting based on pivotal trials.
-
Filed BLA for imsidolimab in GPP supported by positive Phase 3 data.
-
Announced participation and presentation timing at J.P. Morgan Healthcare Conference.
-
FDA lifted partial clinical hold on tradipitant and confirmed PDUFA date.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Conference Call and Webcast to Follow
Vanda will host a conference call at 4:30 PM ET on Wednesday, February 11, 2026, during which management will discuss the fourth quarter and full year 2025 financial results and other corporate activities. To participate in the conference call, please dial 1-888-596-4144 (domestic) or 1-646-968-2525 (international) and use passcode 8728050.
The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Wednesday, February 11, 2026, beginning at 8:30 PM ET and will be accessible until Wednesday, February 18, 2026, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 8728050.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-11-2026-302679562.html
SOURCE Vanda Pharmaceuticals Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.